DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was downgraded by equities researchers at TheStreet from a “b” rating to a “c+” rating in a research report issued on Wednesday.

Other research analysts have also recently issued reports about the company. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a report on Thursday, July 13th. HC Wainwright started coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price objective on the stock. BidaskClub upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $66.00 price objective (down from $70.00) on shares of DENTSPLY SIRONA in a report on Thursday. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $66.75.

DENTSPLY SIRONA (XRAY) opened at 55.50 on Wednesday. The company has a market capitalization of $12.72 billion, a price-to-earnings ratio of 35.71 and a beta of 1.26. DENTSPLY SIRONA has a 52 week low of $55.00 and a 52 week high of $65.68. The company’s 50-day moving average price is $63.15 and its 200-day moving average price is $62.30.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The business had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.76 EPS. Equities analysts forecast that DENTSPLY SIRONA will post $2.78 earnings per share for the current fiscal year.

WARNING: “DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Downgraded by TheStreet” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/08/11/dentsply-sirona-inc-nasdaqxray-downgraded-by-thestreet.html.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Teachers Advisors LLC boosted its position in DENTSPLY SIRONA by 18.5% in the fourth quarter. Teachers Advisors LLC now owns 323,176 shares of the medical instruments supplier’s stock worth $18,657,000 after buying an additional 50,432 shares during the period. Chevy Chase Trust Holdings Inc. boosted its position in DENTSPLY SIRONA by 1.5% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 202,398 shares of the medical instruments supplier’s stock worth $12,638,000 after buying an additional 2,992 shares during the period. Raymond James Trust N.A. boosted its position in DENTSPLY SIRONA by 11.7% in the first quarter. Raymond James Trust N.A. now owns 6,031 shares of the medical instruments supplier’s stock worth $377,000 after buying an additional 630 shares during the period. Creative Planning boosted its position in DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock worth $425,000 after buying an additional 70 shares during the period. Finally, Gulf International Bank UK Ltd boosted its position in DENTSPLY SIRONA by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 74,565 shares of the medical instruments supplier’s stock worth $4,655,000 after buying an additional 1,000 shares during the period. Institutional investors own 95.17% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.